News about Market

USFDA Grants ODD to Zydus' Desidustat for Beta-Thalassemia Treatment

Desidustat, a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI), has received Orphan Drug Designation (ODD) from the USFDA. The designation grants eligibility for up to seven years of marketing exclusivity upon approval and highlights Desidustat’s potential to boost haemoglobin and red blood cell production.

Market | 06/11/2025 | By Dineshwori

Cipla to Acquire Inzpera Healthsciences for INR 110 Crore

Cipla Limited has announced that it will acquire a 100 percent stake in Inzpera Healthsciences Limited for a total consideration of approximately INR 110 crore.

Market | 05/11/2025 | By Darshana |  132

Kimberly-Clark to Acquire Tylenol Maker Kenvue in Over 40 Billion Dollar Deal

Kimberly-Clark has announced plans to acquire Kenvue, the company behind Tylenol and other well-known consumer health brands, in a cash-and-stock transaction valued at approximately 48.7 billion dollars.

Market | 04/11/2025 | By Darshana

Merck Foundation Unveils USD 22 Million Programme to Enhance Cardiovascular Care across US

The Merck Foundation has launched a USD 22 million programme to strengthen cardiovascular care across the United States, awarding grants to 11 organisations to develop and implement evidence-based initiatives aimed at improving outcomes in underserved communities facing barriers to timely heart disease care.

Market | 04/11/2025 | By Dineshwori

Glenmark to Launch 8.4% Sodium Bicarbonate Injection in the US Market

Glenmark Pharmaceuticals has announced its upcoming launch of 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial in the US market.

Market | 04/11/2025 | By Dineshwori

PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc

Under the Definitive Agreement, PharmaDrug will acquire up to a 40 percent equity interest in Canurta, to be completed in two tranches through the issuance of an aggregate of 83,645,316 common shares of PharmaDrug (PHRX Shares) at a deemed price equal to the 20-day volume-weighted average price immediately prior to each closing.

Market | 01/11/2025 | By Dineshwori |  132

Novo Nordisk Makes Unsolicited USD 6.5 Billion Bid to Acquire Metsera

Novo Nordisk, a leading global healthcare company founded in 1923 and headquartered in Denmark, has announced that it has submitted an unsolicited proposal to acquire Metsera, Inc.

Market | 01/11/2025 | By Darshana |  111

Breckenridge Launches Everolimus Tablets, 1mg, generic version of Zortress

Breckenridge Pharmaceutical has announced the launch of Everolimus Tablets, 1 mg, the generic equivalent of Zortress. An mTOR inhibitor immunosuppressant, Everolimus is indicated for the prevention of organ rejection in adult kidney and liver transplant patients and will be available through retail, mail-order pharmacies, and clinics.

Market | 31/10/2025 | By Dineshwori

LillyDirect and Walmart Pharmacy Launch Retail Pick-Up for Zepbound at DTC Pricing

Walmart, with nearly 4,600 pharmacies nationwide, will serve as the first in-store pickup pharmacy for LillyDirect's self-pay single-dose vials.

Market | 30/10/2025 | By Dineshwori |  159

GSK and Empirico Sign Licensing Deal for Respiratory Oligonucleotide

Oligonucleotide therapies, including siRNA, offer the potential to modulate gene expression and target diseases beyond the reach of traditional drugs. EMP-012 adds to GSK’s growing oligonucleotide pipeline across respiratory, immunology and inflammation, and infectious disease portfolios.

Market | 29/10/2025 | By Dineshwori